Sanofi India · NSE: SANOFI · BSE: 500674
Q4 FY20 results · Jan–Mar 2020
Sanofi India reported revenue from operations of ₹784.50 crore (up 9.4% from Q4 FY19) and net profit of ₹85.40 crore (down 8.1% from Q4 FY19) for Q4 FY20 (Jan–Mar 2020), on a standalone basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 784.50 | 717.30 | +9.4% | 826.30 | −5.1% |
| Other income | 29.50 | 23.00 | +28.3% | 24.80 | +19.0% |
| Total income | 814.00 | 740.30 | +10.0% | 851.10 | −4.4% |
| Profit before tax | 134.60 | 150.70 | −10.7% | 161.30 | −16.6% |
| Net profit for the period | 85.40 | 92.90 | −8.1% | 97.30 | −12.2% |
| EPS, basic (₹) | 37.08 | 40.34 | −8.1% | 42.26 | −12.3% |
| Net margin (%) | 10.9 | 13.0 | 11.8 |
Standalone
- Filed with BSE
- 20 May 2020, 12:58 IST
- Board meeting
- 19 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE